Stephens Inc Argenx Se Transaction History
Stephens Inc
- $6.94 Billion
- Q2 2025
A detailed history of Stephens Inc transactions in Argenx Se stock. As of the latest transaction made, Stephens Inc holds 633 shares of ARGX stock, worth $426,103. This represents 0.01% of its overall portfolio holdings.
Number of Shares
633
Previous 517
22.44%
Holding current value
$426,103
Previous $305,000
14.1%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARGX
# of Institutions
498Shares Held
28.4MCall Options Held
330KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.62 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.88 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.44 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.3 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$831 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $37.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...